Perrigo Company plc
Profit after direct costs
Core business profitability
Bottom line profitability
Top line growth rate
Flow of revenue through cost categories to net income
| Item | Trend | 2021 | 2022 | 2023 | 2024 | 2025 | YoY Change |
|---|---|---|---|---|---|---|---|
Total Revenue | 4.14B | 4.45B | 4.66B | 4.37B | 4.25B | -2.8% | |
| Cost of Revenue | (2.72B) | (3.00B) | (2.98B) | (2.83B) | (2.76B) | -2.5% | |
Gross Profit | 1.42B | 1.46B | 1.68B | 1.54B | 1.49B | -3.1% | |
| Operating Expenses | |||||||
| Research & Development | (122.00M) | (123.10M) | (122.50M) | (112.20M) | (95.40M) | -15.0% | |
| Selling, General & Administrative | (1.11B) | (1.21B) | (1.27B) | (1.11B) | (526.50M) | -52.7% | |
| Selling & Marketing | (629.40M) | (697.80M) | (752.30M) | (644.60M) | (526.50M) | -18.3% | |
| Depreciation & Amortization | (312.20M) | (338.60M) | (359.50M) | (325.90M) | (337.50M) | 3.6% | |
Operating Income (EBIT) | 410.40M | 78.90M | 151.90M | 112.90M | 343.30M | 204.1% | |
| Non-Operating Items | |||||||
| Interest Income | — | — | — | — | — | — | |
| Interest Expense | (125.00M) | (156.00M) | (173.80M) | (187.80M) | (162.50M) | -13.5% | |
| Other Income/Expenses (Net) | -151.70M | -218.00M | -160.20M | -193.60M | -1.64B | 747.7% | |
Income Before Tax | 258.70M | -139.10M | -8.30M | -80.70M | -1.30B | 1508.3% | |
| Income Tax Expense | (389.60M) | (8.20M) | (3.90M) | (80.00M) | (104.40M) | 30.5% | |
Net Income | -68.90M | -140.60M | -12.70M | -171.80M | -1.43B | 729.7% | |
| Per Share Metrics | |||||||
| Earnings Per Share (Basic) | $-1 | $-1 | $-0 | $-1 | $-10 | 723.2% | |
| Weighted Avg Shares Outstanding | 133.60M | 134.50M | 135.30M | 137.40M | 138.50M | 0.8% | |
| Weighted Avg Shares Outstanding (Diluted) | 133.60M | 134.50M | 135.30M | 137.40M | 138.50M | 0.8% | |
EBITDA | 695.90M | 355.50M | 525.00M | 433.00M | -797.90M | -284.3% |
Explore PRGO
PRGO in the Healthcare
Small Cap